Four different hydrated iron phosphates were prepared as pure crystalline powders by precipitation in aqueous solutions under controlled pH: strengite, FePO 4 ·2H 2 O ( Pbca; a = 9.8923(6) Å, b = 10.125(1) Å, c = 8.729(1) Å); metastrengite I, FePO 4 ·2H 2 O ( Pbnm; a = 5.226(2) Å, b = 10.026(3) Å, c = 8.917(3) Å); metastrengite II, FePO 4 ·2H 2 O ( P 2 1 / n; a = 5.3276(3) Å, b = 9.800(1) Å, c = 8.7129(6) Å, β = 90.532(6)°); and spheniscidite, NH 4 (Fe 2 (PO 4 ) 2 OH·H 2 O)·H 2 O ( P 2 1 / n; a = 9.808(3) Å, b = 9.727(3) Å, c = 9.866(3) Å, β = 102.85(2)°). Thermogravimetric analysis revealed slightly more than 2 H 2 O molecules per FePO 4 for the first three compounds, the excess being considered as adsorbed on the powders' surface. Temperature-controlled X-ray diffraction allowed isolation and determination of the stability domains of a large number of FePO 4 polymorphs which may, or may not, reabsorb H 2 O upon exposure to ambient air. All these phases, after careful optimization of the electrode preparation, may be reversibly reduced to ∼90% of their theoretical capacities within the 2−4 V vs Li + /Li region.
No takes yet. Share an insight, caveat, or question.
Reale et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: